A Prospective, Non-interventional Multi-center Observational Study to Evaluate the Long-term Effectiveness and Safety of Tocilizumab in Patients With Active Rheumatoid Arthritis in Daily Practice
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Rheumatoid Arthritis
Both
Rheumatoid Arthritis
Trial Information
A Prospective, Non-interventional Multi-center Observational Study to Evaluate the Long-term Effectiveness and Safety of Tocilizumab in Patients With Active Rheumatoid Arthritis in Daily Practice
Inclusion Criteria:
- Adult patients, >/= 18 years of age
- Active moderate to severe rheumatoid arthritis
- Inadequate response or intolerant to previous therapy with one or more
disease-modifying antirheumatic drugs (DMARDs) or tumour necrosis factor (TNF)
antagonists
- Prescription of RoActemra/Actemra according to label
Exclusion Criteria:
N/A
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Proportion of patients with clinical remission defined as disease activity score DAS28 < 2.6
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Germany: Paul-Ehrlich-Institut
Study ID:
ML22928
NCT ID:
NCT01194401
Start Date:
February 2010
Completion Date:
December 2016
Related Keywords:
- Rheumatoid Arthritis
- Arthritis
- Arthritis, Rheumatoid
Name | Location |
|---|
